Home›Stock Screener›Medistep Healthcare›Financial Statements

Medistep Healthcare Financial Statements

3 Years of Data
2026 - 2024

Medistep Healthcare financial statements. In FYNone, Medistep Healthcare (MEDISTEP) reported revenue ₹21 Cr, net profit ₹2 Cr and EPS ₹1.60, with a net profit margin of 8.5% and ROE of 15.8%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse MEDISTEP shareholder distribution to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.45% 2026 data
EBITDA Margin 11.27% 2026 data
Operating Margin 12.00% 2026 data
Return on Assets 12.00% 2026 data
Return on Equity 15.79% 2026 data

Balance Sheet Ratios

Equity Ratio 76.00% 2026 data
Asset Turnover 1.42 2026 data

MEDISTEP Revenue, Net Profit & EBITDA — Year-on-Year Growth

MEDISTEP YoY (March 2026 vs Period) — revenue -70.4%, net profit -66.7%, EBITDA -75.0%, expenses -69.8%. Read Medistep Healthcare dividend policy for the complete payout history and dividend yield track record.

Revenue Growth
-70.4%
Year-over-Year
Net Profit Growth
-66.7%
Year-over-Year
EBITDA Growth
-75.0%
Year-over-Year
Expense Growth
-69.8%
Year-over-Year
Assets Growth
+117.4%
Year-over-Year
Equity Growth
+123.5%
Year-over-Year
Financing Cash Flow Growth
+1800.0%
Year-over-Year

MEDISTEP Income Statement — Revenue, EBITDA & Net Profit

Medistep Healthcare revenue ₹21 Cr, EBITDA ₹2 Cr, net profit ₹2 Cr, EPS ₹1.60 (None) — net profit margin 8.5%. For live price, earnings ratios and company overview, see MEDISTEP screener.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024
Revenue 21 71 50 32
Expenses 19 63 44 28
EBITDA 2 8 6 4
Operating Profit Margin % 5.00% 12.00% 11.00% 13.00%
Depreciation 0 0 0 0
Interest 0 0 0 0
Profit Before Tax 2 8 6 4
Tax 1 2 1 1
Net Profit 2 6 4 3
Earnings Per Share (₹) 1.60 4.68 4.01 19.96

MEDISTEP Balance Sheet — Assets, Liabilities & Shareholders' Equity

MEDISTEP total assets ₹50 Cr, total equity ₹38 Cr, total liabilities ₹ Cr (2026) — ROE 15.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024
ASSETS
Total Assets 50 23 15
Current Assets 50 23 15
Fixed Assets 0 0 0
Capital Work in Progress 0 0 0
Investments 0 0 0
Other Assets 50 23 15
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 38 17 12
Share Capital 14 11 5
Reserves & Surplus 24 7 7

MEDISTEP Cash Flow Statement — Operating, Investing & Financing

Medistep Healthcare operating cash flow ₹-20 Cr, investing ₹0 Cr, financing ₹19 Cr, net cash flow ₹-1 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024
Operating Activities -20 0 -7
Investing Activities 0 0 0
Financing Activities 19 1 7
Net Cash Flow -1 1 0